Humacyte, Inc. (HUMA)
0.5935
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 11:18
Humacyte Price : 0.5935 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 0.5711 | 0.6111 | 0.57 | 0.5966 | 5.179M |
| Sep 01, 2026 | 0.598 | 0.6014 | 0.57 | 0.5704 | 16.54M |
| Aug 31, 2026 | 0.65 | 0.65 | 0.5838 | 0.6014 | 13.54M |
| Aug 28, 2026 | 0.69 | 0.6954 | 0.6401 | 0.6501 | 4.922M |
| Aug 27, 2026 | 0.70 | 0.7082 | 0.687 | 0.6927 | 2.964M |
| Aug 26, 2026 | 0.71 | 0.7119 | 0.67 | 0.6816 | 5.678M |
| Aug 25, 2026 | 0.663 | 0.73 | 0.6601 | 0.7012 | 5.921M |
| Aug 24, 2026 | 0.675 | 0.6936 | 0.6424 | 0.6622 | 3.759M |
| Aug 21, 2026 | 0.6741 | 0.70 | 0.6345 | 0.6422 | 9.366M |
| Aug 20, 2026 | 0.7074 | 0.715 | 0.6627 | 0.6814 | 6.648M |
| Aug 19, 2026 | 0.60 | 0.75 | 0.5964 | 0.7349 | 21.66M |
| Aug 18, 2026 | 0.56 | 0.5893 | 0.5401 | 0.5817 | 9.262M |
| Aug 17, 2026 | 0.6098 | 0.6099 | 0.5422 | 0.5606 | 13.74M |
| Aug 14, 2026 | 0.5729 | 0.621 | 0.5261 | 0.6048 | 33.06M |
| Aug 13, 2026 | 0.641 | 0.6775 | 0.55 | 0.55 | 32.78M |
| Aug 12, 2026 | 0.6438 | 0.6652 | 0.6156 | 0.665 | 11.17M |
| Aug 11, 2026 | 0.7399 | 0.745 | 0.71 | 0.71 | 3.595M |
| Aug 10, 2026 | 0.7202 | 0.7499 | 0.7023 | 0.7445 | 2.847M |
| Aug 07, 2026 | 0.7128 | 0.7398 | 0.7021 | 0.7182 | 2.278M |
| Aug 06, 2026 | 0.7042 | 0.73 | 0.6835 | 0.7096 | 1.957M |
| Aug 05, 2026 | 0.725 | 0.7316 | 0.7011 | 0.7288 | 2.055M |
| Aug 04, 2026 | 0.6802 | 0.7250 | 0.6802 | 0.7122 | 2.910M |
| Aug 03, 2026 | 0.66 | 0.7056 | 0.65 | 0.6893 | 3.267M |
| Jul 31, 2026 | 0.6855 | 0.6899 | 0.6441 | 0.6534 | 1.747M |
| Jul 30, 2026 | 0.6457 | 0.685 | 0.626 | 0.6716 | 4.087M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 442.44 |
| Altimmune, Inc. | 3.25 |
| Protalix Biotherapeutics, Inc. | 2.58 |
| Taysha Gene Therapies, Inc. | 5.58 |
| Agenus, Inc. | 8.23 |
Price Related Metrics
| PS Ratio | 54.36 |
| PEG Ratio | -0.1672 |
| Price to Book Value | 5.274 |
| Earnings Yield | -82.49% |
| Market Cap | 164.87M |
| PEGY Ratio | -0.1672 |